INVITED REVIEW
Physiological significance of volume-regulatory transporters

W. Charles O'Neill

Renal Division, Department of Medicine, and Department of Physiology, Emory University School of Medicine, Atlanta, Georgia 30322


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
DETERMINANTS OF CELL VOLUME
REGULATORY VOLUME INCREASE
REGULATORY VOLUME DECREASE
CHANGES IN THE SET...
SUMMARY
REFERENCES

Research over the past 25 years has identified specific ion transporters and channels that are activated by acute changes in cell volume and that serve to restore steady-state volume. The mechanism by which cells sense changes in cell volume and activate the appropriate transporters remains a mystery, but recent studies are providing important clues. A curious aspect of volume regulation in mammalian cells is that it is often absent or incomplete in anisosmotic media, whereas complete volume regulation is observed with isosmotic shrinkage and swelling. The basis for this may lie in an important role of intracellular Cl- in controlling volume-regulatory transporters. This is physiologically relevant, since the principal threat to cell volume in vivo is not changes in extracellular osmolarity but rather changes in the cellular content of osmotically active molecules. Volume-regulatory transporters are also closely linked to cell growth and metabolism, producing requisite changes in cell volume that may also signal subsequent growth and metabolic events. Thus, despite the relatively constant osmolarity in mammals, volume-regulatory transporters have important roles in mammalian physiology.

cell volume; regulatory volume increase; regulatory volume decrease; sodium-potassium-chloride cotransporter; sodium-proton antiporter


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
DETERMINANTS OF CELL VOLUME
REGULATORY VOLUME INCREASE
REGULATORY VOLUME DECREASE
CHANGES IN THE SET...
SUMMARY
REFERENCES

THE NECESSITY TO RAPIDLY REGULATE volume after shrinkage or swelling is obvious in cells from lower organisms, which are continually exposed to osmotic stress. Yet, in mammals, where osmolarity of the internal milieu is carefully regulated, cells also exhibit rapid volume-regulatory responses. Are volume-regulatory pathways in mammalian cells merely a vestige that have no significant physiological role? The answer to this question lies in the realization that mammalian cells are still subject to volume changes, despite a relatively constant osmolarity. This is most apparent in transporting epithelia, where slight changes in the large apical and basolateral fluxes could lead to rapid changes in cell volume. Furthermore, even if cell volume were not threatened, mechanisms are still needed to alter cell volume, such as during hypertrophy and atrophy, apoptosis, and differentiation. Thus mammalian cells clearly require volume-regulatory mechanisms, despite their isosmotic existence. Although the principal volume-regulatory transporters have been identified and characterized, their activation by changes in cell volume is poorly understood and their physiological role is largely unexplored. This review focuses on the salient points of volume-regulatory ion transporters that have direct relevance to mammalian physiology, with particular emphasis on the distinction between anisosmotic and isosmotic volume regulation, the role of intracellular Cl-, and the need for cell volume regulation in vivo. Space does not permit a detailed discussion of the intracellular sensing and signaling mechanisms, and readers are referred to a recent, comprehensive review on this subject (94).


    DETERMINANTS OF CELL VOLUME
TOP
ABSTRACT
INTRODUCTION
DETERMINANTS OF CELL VOLUME
REGULATORY VOLUME INCREASE
REGULATORY VOLUME DECREASE
CHANGES IN THE SET...
SUMMARY
REFERENCES

In discussing cell volume it is important to distinguish between factors that determine steady-state volume and mechanisms that correct acute perturbations in steady-state volume. This has been a source of confusion, and it is best to consider these as entirely separate processes. Transporters responsible for correcting acute changes in cell volume are usually not active at steady-state volume. Thus steady-state cell volume is not a balance between their ongoing, opposing actions. Rather, cells appear to establish a steady-state volume and then activate volume-regulatory transporters only when cell volume deviates from this "set point." This is far more efficient than having opposing volume-regulatory transporters continuously active.

Steady-State Cell Volume

Mere existence in an isosmotic environment represents a continual threat to cell volume and integrity due to the large concentration of impermeant, negatively charged molecules within cells, such as proteins, nucleic acids, and other organophosphates. In addition to the osmotic force generated by the molecules themselves, there is an additional osmotic force due to an asymmetrical distribution of permeant ions created by the impermeant anions. Known as the Gibbs-Donnan equilibrium (65, 115), this is actually a steady-state disequilibrium. Unless the osmotic gradient is counterbalanced, there would be continuous influx of water and ions. In theory this counterbalancing could be accomplished by hydrostatic pressure, but it is highly unlikely that the plasma membrane can generate the tension required to balance the Donnan effect (115). In the absence of an opposing force, cells must either restrict permeability or actively extrude fluid. Because mammalian cells are generally quite permeable to water and there is no evidence for active transport of water, it must be solute that is actively transported and has restricted diffusion. This is illustrated by ionophores and other compounds that increase membrane permeability to Na+ and K+, which produce cell swelling without altering the Gibbs-Donnan "equilibrium." In addition, this confirms that membrane tension is not responsible for maintaining steady-state cell volume.

Another simple maneuver that causes cell swelling is replacement of extracellular Na+ with K+. Because neither the Gibbs-Donnan equilibrium nor other osmotic forces are altered (115), elimination of the outward K+ gradient is directly implicated in cell swelling. By virtue of the selective permeability of the plasma membrane to K+ over Na+, this gradient results in an outward K+ current and a negative membrane potential that dictates a low intracellular concentration of permeant anions, primarily Cl-. The source of energy is ultimately the Na+-K+ pump, explaining why its inhibition often leads to cell swelling. This ability to extrude Cl- (coupled with extrusion of Na+ by the Na+-K+ pump) appears to be the principal mechanism that maintains steady-state cell volume. In cells with high anion permeability and low membrane potential, such as erythrocytes, it is the net cation extrusion by the Na+-K+ pump coupled with low membrane permeability to both Na+ and K+ that limits Cl- entry. In erythrocytes from carnivores, which lack Na+-K+ pumps, net cation extrusion occurs through combined action of Ca2+ pumps (Ca2+-ATPases) and Na+/Ca2+ exchangers. The former generates a very large inward Ca2+ gradient that is then used to pump out Na+ via the latter (127). Cl- accompanies Na+ efflux by virtue of the electrogenicity of both transporters.

Acute Changes in Steady-State Volume

The steady-state disequilibrium that maintains cell volume can be threatened by changes in extracellular osmolarity, but a far more common threat is a change in the cellular content of osmotically active molecules, so-called isosmotic volume change. Cell volume can be viewed as a balance between the osmotic effects of high concentrations of impermeant anions and low concentrations of Cl- within cells, and changes in either without offsetting changes in the other can alter cell volume. Changes in the former occur through synthesis, degradation, and fluxes, whereas changes in intracellular Cl- concentration ([Cl-]i) arise from altered fluxes or membrane potential. Do the mechanisms described above for maintenance of steady-state cell volume protect cells from acute changes in cell volume as well? Cell shrinkage can reduce K+ conductance (37, 166), which should increase cell volume. However, the response would be slow and does not appear to contribute substantially to volume recovery (166). Although cell swelling has the opposite effect of increasing K+ conductance, this occurs through channels distinct from those responsible for basal K+ conductance.

Cells instead recruit additional mechanisms to correct acute deviations in their volume. These processes, termed regulatory volume increase (RVI) and regulatory volume decrease (RVD), occur through activation of specific transporters in the plasma membrane that mediate net fluxes of osmotically active molecules (and therefore water). Not surprisingly, both [Cl-]i and macromolecule concentration play key roles in governing these volume-regulatory responses. A further adaptation to osmotic stress is the accumulation of organic osmolytes such as sorbitol, sn-glycero-3-phosphorylcholine, betaine, and taurine, which occurs in response to increased ionic strength rather than cell shrinkage (70, 207) and therefore is not truly a volume-regulatory mechanism. Instead, these compounds replace high intracellular salt concentrations that can perturb protein structure and impair enzyme function (18, 70), enabling cells to function in high osmolarity, such as in the renal medulla. Organic osmolytes also appear in the brain during chronic hypernatremia and comprise the so-called idiogenic osmoles (195). Organic osmolytes do have an impact on volume regulation, because they must be rapidly removed when normal osmolarity is restored in order to prevent cell swelling.

The mechanism by which cells sense changes in their volume is unknown but clearly is not through changes in osmolarity, ionic strength, or ion concentration, since isosmotic volume changes also activate RVI and RVD. Cell volume could be sensed chemically as changes in the intracellular concentration of impermeant molecules or mechanically through some form of stretch receptor. The former possibility, proposed by Minton et al. (129) and based on the concept of macromolecular crowding, is supported by direct experimental data. According to this theory, it is not cell volume per se that is regulated but rather the state of intracellular water. In erythrocytes, volume-regulatory transporters can be activated in the absence of changes in cell volume by altering intracellular protein concentration or by adding agents that perturb protein hydration (157). These findings have been extended to nonerythroid cells, specifically renal tubular cells (83) and barnacle muscle (200). The question that remains is the nature of the sensor for macromolecular crowding. Mechanical sensing of cell volume is an attractive theory, since cell structure is directly threatened, but the evidence is indirect. Agents that perturb the actin cytoskeleton can inhibit RVD (24, 25, 42, 49, 184), and channels activated directly by membrane stretch can also be activated by cell swelling (176). Mechanical sensing of changes in cell volume remains speculative since no role for the cytoskeleton has been demonstrated in RVI, and the role of stretch-activated channels in RVD remains unproven. The issue of how cells sense their volume is far from resolved, and it is quite possible that both chemical and mechanical sensors are employed.

Consequences of Cell Shrinkage and Swelling

What exactly are the detrimental effects of changes in cell volume that volume-regulatory mechanisms are designed to prevent? Aside from extreme results such as cell lysis, this is an area that has received little attention. The most obvious effects of changing cell volume are mechanical, since the function of many cells depends on their architecture. Close examination reveals blebbing of the plasma membrane after severe hypotonic swelling (217). In addition to direct distortion, shrinkage and swelling also induce rapid changes in the actin cytoskeleton (Ref. 66 and P. B. Perry and W. C. O'Neill, unpublished observations), presumably as a protective measure to ease tension on the plasma membrane. At the tissue level, swelling of parenchymal cells can compromise regional blood flow, possibly aggravated by swelling of vascular endothelium and smooth muscle (17). Due to its rigid confines, the brain is the predominant site of morbidity from hyponatremia and hypernatremia, and, accordingly, is the tissue that exhibits the most complete volume regulation. At the cellular level, swelling and shrinkage could alter metabolic reactions through changes in the concentrations of enzymes and substrates. In this regard, cell swelling is more of a problem than cell shrinkage, which is well tolerated. For instance, in alveolar macrophages, hypotonic swelling decreases O2 consumption and increases lactate production while there is little effect of hypertonic shrinkage (169). In mouse L cells, halving cell volume with extracellular sorbitol does not alter growth or the oxidation or metabolism of glucose (119). In both these studies and in other studies, severe hypertonic shrinkage (osmolarity >700 mosM) does impair cell growth and metabolism, but this appears to be an effect of increased ionic strength rather than cell shrinkage (18, 70).


    REGULATORY VOLUME INCREASE
TOP
ABSTRACT
INTRODUCTION
DETERMINANTS OF CELL VOLUME
REGULATORY VOLUME INCREASE
REGULATORY VOLUME DECREASE
CHANGES IN THE SET...
SUMMARY
REFERENCES

Volume-Regulatory Transporters

A seemingly simple way for cells to increase volume after shrinkage is by the opening of Na+ channels, with Cl- following, but this appears to be a rare event (214). Instead, volume regulation occurs primarily through electroneutral transporters, principally the Na+-K+-2Cl- cotransporter (NKCC1) and the Na+/H+ antiporter (NHE1). NKCC1 mediates coupled influx of Na+, K+, and Cl- and is found in virtually all cells. It is distinguished by its sensitivity to sulfamoylbenzoic acid derivatives, the so-called "loop" diuretics such as furosemide and bumetanide (56). NHE1, the ubiquitous NHE isoform, produces a net inward movement of ions by coupling with Cl-/HCO-3 exchange (Fig. 1). The combined effect is influx of Na+ and Cl- with efflux of H+ and HCO-3. The latter two combine to form CO2, which diffuses back into the cell to regenerate H+ and HCO-3. The net result is influx of NaCl. The Na+-K+ pump is a necessary participant in RVI, exchanging Na+ for K+. The pump also provides the thermodynamic energy for RVI by maintaining a low intracellular Na+ concentration and, indirectly, a low [Cl-]i. Amino acid uptake can also contribute to RVI (30), but this is probably minor at normal extracellular amino acid concentrations.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 1.   Transporters involved in regulatory volume increase. NKCC1, Na+-K+-2Cl- transporter; NHE1, Na+/H+ antiporter.

The mechanism by which cell shrinkage activates NKCC1 or NHE1 is unknown. Because activation occurs within minutes, it cannot be due to increased synthesis of transporters. Current data suggest that protein phosphorylation is involved. Activation of NKCC1 by shrinkage is associated with phosphorylation of the transporter (on serine and threonine, but not tyrosine) and can be blocked by kinase inhibitors and mimicked by inhibitors of protein phosphatases (90, 163). Although these agents have a similar effect on NHE1 activity (9), cell shrinkage does not increase phosphorylation of the transporter (53). The data imply the existence of a volume-sensitive protein kinase (or more than one) that phosphorylates NKCC1 and a regulatory protein that activates NHE1. Hopefully, the recent demonstration of a volume-sensitive kinase that phosphorylates NKCC1 in vitro will lead to identification of this kinase (145). Although the identity of this kinase is unknown, other volume-sensitive kinases have been tentatively identified. One of these is myosin light chain kinase (MLCK), which is activated by shrinkage in vascular endothelial and smooth muscle cells (89), mesangial cells (203), and glial cells (188). Inhibition of MLCK blocks activation of NKCC1 in shrunken endothelial cells (89) and activation of NHE1 in shrunken astrocytes (188). However, MLCK is not the volume-sensitive kinase that phosphorylates NKCC1, and the mechanism by which myosin light chain phosphorylation influences NKCC1 and NHE1 is unknown. Hypertonicity increases phosphorylation of stress-activated protein kinases and mitogen-activated protein (MAP) kinases (45, 69). It is not known whether this is an effect of hypertonicity or cell shrinkage, and phosphorylation of MAP kinase also occurs after hypotonicity, suggesting a nonspecific stress response rather than a specific response to cell volume. However, phosphorylation and activation of the tyrosine kinases p59fgr and p56/59hck occurred in neutrophils shrunken both hypertonically and isosmotically (91), directly implicating cell shrinkage.

Hypertonic vs. Isosmotic Shrinkage

It is important to distinguish between these two fundamentally different types of cell shrinkage because the response frequently differs, a fact that is often not appreciated. Hypertonic shrinkage removes only water from cells, whereas isosmotic shrinkage results from loss of osmotically active molecules, usually KCl. Examples of isosmotic shrinkage include returning cells to isotonic medium after volume regulation in hypotonic medium, substituting external Na+ or Cl- with impermeant molecules, and increasing intracellular Ca2+ concentration ([Ca2+]i) to open K+ and Cl- channels. RVI almost always occurs after isosmotic shrinkage but is infrequent after hypertonic shrinkage. Although occasionally noted, absence of hypertonic RVI has largely been ignored and never systematically examined. Table 1 is an attempt at a complete listing of mammalian cells and tissues in which hypertonic RVI has been examined. For this purpose, RVI was defined as a significant volume increase occurring within 1 h. Although hypertonic RVI does correlate somewhat with tissue type or origin, being more common in glial, neural, and epithelial cells, there are clearly discrepancies between studies on the same tissue or cell type. Absence of hypertonic RVI cannot be explained by lack of volume-regulatory transporters, because most of the cells listed undergo RVI after isosmotic shrinkage. One exception is mature human erythrocytes, which do have a low complement of transporters.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Volume-regulatory response to hypertonic shrinkage in various mammalian tissues and cells

Can thermodynamics explain the lack of hypertonic RVI? When hypertonicity is produced with an impermeant molecule such as sucrose or mannitol, the concentration of extracellular ions is unchanged while intracellular ions increase in concentration, thereby reducing the driving force for influx. This can actually lead to further cell shrinkage (101) and is accentuated by the occasional use of impermeant molecules in place of NaCl in the reference isotonic solution. However, hypertonic RVI is still infrequent when NaCl is the osmotic agent. Given reasonable estimates of intracellular ion activities, activation of NKCC1 should result in net influx of ions, primarily because of the inwardly directed Cl- gradient. In the absence of accurate determinations of intracellular ion activities, it can always be argued that NKCC1 is at equilibrium. However, substitution of external Na+ with K+ to equalize their concentrations still does not result in net influx and RVI, despite the fact that the driving force for influx is increased sevenfold (143, 168). Furthermore, thermodynamics cannot explain a lack of hypertonic RVI by NHE1 and anion exchange, provided some CO2 and HCO-3 are present. These results indicate that the lack of RVI in hypertonic medium is a regulatory event rather than a thermodynamic effect. This could be because the responses to the two types of shrinkage are inherently different (40) or could be explained by superimposed regulatory effects of ionic strength or intracellular ion concentrations. In either event it is clear that cells can sense how they are being shrunk.

Although the difference between isosmotic and hypertonic shrinkage could be sensed as a change in ionic strength or an agonist-induced signal, the most logical candidate is [Cl-]i. Cl- is a minority anion in most cells, yet it is the major permeant anion, with the majority of anions being impermeant proteins and organophosphates. While hypertonic shrinkage increases [Cl-]i in parallel with all other cytoplasmic constituents, [Cl-]i decreases with isosmotic shrinkage, since the fluid moving out of cells has a higher Cl- concentration than cytoplasm. As with hypertonic shrinkage, the concentration of all other cytoplasmic constituents increases (except for K+, which should change little since it comprises the vast majority of intracellular cations). The decrease in [Cl-]i is actually greater than the decrease in cell volume, making Cl- concentration a more sensitive indicator of changes in cell volume than cell volume itself under isosmotic conditions. As shown in Fig. 2, if Cl- accounts for one third of cellular anions and a cell loses one sixth of its volume via loss of KCl, half the cell Cl- is lost and [Cl-]i theoretically decreases by 40% (1/2 the original Cl- content in 5/6 the original volume). It is not surprising then that [Cl-]i has important effects on volume-regulatory transporters.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Theoretical relationship between intracellular Cl- concentration ([Cl-]i) and cell water during isosmotic shrinkage, where steady-state [Cl-]i comprises one third of intracellular anions and volume changes are mediated by isosmotic fluxes of KCl.

[Cl-]i inhibits NKCC1, and this occurs through inhibition of phosphorylation and probably through a direct effect on the transporter as well. Phosphorylation of NKCC1 is stimulated by lowering [Cl-]i and inhibited by raising [Cl-]i (57, 111), probably via effects on the same kinase activated by cell shrinkage (110). However, this cannot be the principal mechanism that blocks hypertonic RVI, since there is still a substantial increase in NKCC1 phosphorylation with hypertonic shrinkage, suggesting that Cl- has an additional, direct effect on NKCC1. The inhibition of NKCC1 by Cl- in internally perfused squid axons (16) is consistent with this hypothesis. In a sense this represents classic feedback inhibition of NKCC1 and provides an ideal yet simple mechanism for regulating cell volume. The nature of this Cl- effect is unclear. In endothelial cells, hypertonic and isosmotic shrinkage activate unidirectional influx through NKCC1 to about the same degree, yet net influx only occurs after the latter (143). This suggests that intracellular Cl- blocks net influx while allowing the partial reaction [K+(Rb+)/K+ exchange] to continue. Evidence for inhibition of NKCC1 by internal Cl- has also been obtained in Ehrlich ascites cells (101), salivary acinar cells (168), and tracheal epithelial cells (58). In many cells NKCC1 apparently functions in a similar mode at steady-state volume as well (21, 46, 101, 116, 143, 150), essentially "running in neutral" due to inhibition by intracellular Cl-, yet poised for rapid influx when [Cl-]i decreases. Because cells already expend energy to counteract swelling due to the Gibbs-Donnan equlibrium, it makes little sense to allow net influx via NKCC1 or NHE1 at steady-state volume.

The mechanism by which hypertonic shrinkage prevents RVI by NHE1 has not been examined. In the absence of CO2/HCO-3, RVI could be limited by the alkalinization that accompanies Na+ influx and rapidly shuts off NHE1. For instance, if shrinkage produces a 0.2 unit alkaline shift in the pH set point for NHE1 and the internal buffering capacity is 30 mM/pH unit, NHE1 shuts off after an influx of only 6 mM Na+. The fact that more substantial RVI via NHE1 can occur in the nominal absence of CO2/HCO-3 (after isosmotic shrinkage) indicates that there is still enough CO2/HCO-3 to permit some Cl-/HCO-3 exchange. Because hypertonic RVI requires more Na+ influx, it may be substantially slower under these conditions. However, there appears to be an additional mechanism since hypertonic shrinkage can actually suppress activation of NHE1, presumably due to an effect of internal Cl- (168).

Inhibition of RVI by intracellular Cl- may explain the variable responses to hypertonic shrinkage noted in Table 1. Epithelial cells, which frequently exhibit hypertonic RVI, may have a significantly lower [Cl-]i that is below the threshold for inhibition of RVI even after hypertonic shrinkage. Some epithelia that do not exhibit RVI under standard hypertonic conditions do so in the presence of agents that raise cAMP levels (43, 54, 202), most likely via activation of Cl- channels and reduction of [Cl-]i. Hypertonic RVI by C6 glioma cells appears to require additives as well, including insulin and PGE1 (133). This could also be due to a decrease in [Cl-]i, but the possibility that these agents might modulate the inhibitory effect of Cl- cannot be ruled out. An additional additive that confers hypertonic RVI on renal epithelial cells is butyrate (135, 170). The mechanism is not known, but the RVI is only partly accounted for by monovalent ions (170), suggesting that butyrate stimulates the synthesis of organic osmolytes. The occasional observation of hypertonic RVI in other cells and the discrepancies between studies employing similar cells could be due to subtle differences in culture conditions or the inadvertent presence of agonists or growth factors, perhaps autocrine in nature. Hypertonic RVI may also depend on the rate of shrinkage. In renal proximal tubules, no shrinkage occurred when tonicity was increased 1.5 mosM/min, whereas the cells behaved as perfect osmometers at 3 mosM/min (104). A similar response has been described in C6 glioma cells (134), but these cells do exhibit some RVI after acute hypertonic shock (133). The basis for this so-called isovolumetric regulation is unknown but could relate to the fact that [Cl-]i is not markedly elevated during shrinkage. This phenomenon is probably not widespread, since most tissues do not exhibit RVI during hypertonicity in vivo, which also develops gradually.

Hypertonic Shrinkage In Vivo

The lack of RVI in most isolated or cultured cells is supported by data obtained in whole tissue and in vivo. During infusion of mannitol into dogs, the total intracellular water compartment behaves as a perfect osmometer (216), and in perfused skeletal muscle, which accounts for 75% of total intracellular water, there is no recovery of intracellular water after hypertonic shrinkage (68). A 6% increase in osmolarity in rats produced by dehydration decreased total intracellular water by 11% (137), with a decrease noted in muscle and several other tissues except brain. In dehydrated humans, loss of cellular water from skeletal muscle was precisely the inverse of the 7% increase in osmolarity (26), with no increase in the content of K+ or Cl-. Hypertonic infusions of NaCl, sucrose, or mannitol in rabbits also produced the expected decrease in total intracellular water and muscle cell water with no increase in K+ content (3, 192), again indicating absence of RVI. In hypertonically perfused lung, total alveolar cell volume decreased in exact inverse proportion to osmolarity (213), indicating that the lack of RVI extends to other tissues as well. The absence of hypertonic RVI in vivo is consistent with the clinical dictum that water deficits are distributed equally across all compartments.

Based on both in vitro and in vivo data, it appears that mammalian cells are poised to undergo RVI after isosmotic shrinkage but not hypertonic shrinkage. This might seem appropriate since these cells reside in an environment of constant osmolarity. But is the osmolarity of mammalian plasma and interstitial fluid truly that constant? Despite the best efforts of the hypothalamus, kidneys, colon, and skin, significant water losses still occur during water deprivation. Thus osmolarity fluctuates with the frequency of water intake. In various rodents and ungulates, particularly those that reside in arid areas, water loss that exceeds 20% of body weight is well tolerated (112, 181). Deprivation for as short as 1 day can lead to a 6% or greater weight loss (112, 181). Some of this fluid comes from the intestinal lumen (113) and there is also excretion of electrolytes, so the corresponding rise in osmolarity is not as great. Deprivation of water increases plasma osmolarity 6-7% after 8 days in kangaroo rats (193), 4 days in dogs (224), and 3 days in Moroccan goats (76). In humans, strenuous exercise in hot conditions without water can result in water losses up to 5% of body weight (8% of total body water, 7% increase in osmolarity) without functional impairment (26, 100). Because periods of water deprivation are probably common in mammals, hypertonicity appears to be a routine occurrence that is well tolerated.

The lack of hypertonic RVI may instead be due to potential detrimental effects on the organism. Substantial water losses are often well tolerated, without circulatory collapse, because the loss is distributed across all compartments (intracellular, interstitial, and intravascular). If RVI occurred, the water loss would be concentrated in the one third of body water that is not intracellular. A 10% loss of body water would instead result in a 30% decrease in extracellular volume, including intravascular volume. Thus the absence of RVI helps maintain vascular volume during water deprivation, essentially allowing tissues to serve as a water reservoir (112). Another serious consequence of RVI would be the profound transcellular shift of K+. Correction of a mere 1% cell shrinkage via cellular uptake of KCl could decrease plasma K+ concentration as much as 3 mM.

Because of the potential detrimental effects of hypertonic RVI and the seemingly minimal detrimental effects of mild hypertonic shrinkage, RVI may be sacrificed for the benefit of the whole organism. Exceptions appear to be intestinal epithelium (138) and brain (3, 28, 29, 137, 192) and cells cultured from these sites (116, 133). Because intestinal epithelium is one of the few tissues routinely exposed to sudden changes in osmolarity, hypertonic RVI would be appropriate, particularly since cell shrinkage could disrupt the mucosal barrier. The brain is a critical organ with limited capacity to shrink without structural damage because of the inelasticity of the skull. Another exception may be chondrocytes. The extracellular fluid in cartilage is hypertonic compared with plasma, owing to the high concentration of fixed, polyanionic macromolecules, and this can change with applied load (64). Hypertonic RVI is occasionally observed in chondrocytes in situ but not in isolated chondrocytes (Ref. 63 and A. C. Hall, personal communication). The specific mechanism that allows hypertonic RVI to proceed in some tissues and cells but not in others is unknown.

Isosmotic Shrinkage In Vivo

It appears that volume-regulatory pathways in mammalian cells are designed with the dual purpose of avoiding RVI after hypertonic shrinkage yet mediating rapid volume recovery after isosmotic shrinkage. So when does the need for isosmotic RVI arise? Isosmotic shrinkage results from cellular loss of osmotically active molecules, usually K+ and Cl-, since they are the principal permeant ions. This can occur rapidly during agonist stimulation (58, 146, 168). In cultured vascular endothelial cells, cell volume decreases 16% over 10 min in response to Ca2+-mobilizing agonists by virtue of Ca2+-dependent K+ channels (and probably Cl- channels as well). Inhibition of NKCC1 doubles the shrinkage, indicating that RVI is required to stabilize cell volume during agonist stimulation. In addition to maintaining cell volume, this process also prevents large decreases in [Cl-]i that could impair agonist-induced Cl- currents. RVI also occurs during stimulation of secretory epithelia (41, 58, 211) where large solute losses across the apical membrane would lead to rapid shrinkage if not compensated by influx across the basolateral membrane. Not surprisingly, NKCC1 and NHE1 are components of the basolateral membrane and become quite active when apical Cl- channels are open (57, 58, 168). This coupling of apical efflux and basolateral influx via cell volume provides a simple mechanism for maintaining cell volume during large transepithelial fluxes, a process that has been termed homocellular volume regulation (183). Another example of isosmotic shrinkage may be the decrease in mucosal volume of the intestine during fasting (61). In rats, a 15% volume decrease occurs during a 48-h fast and is rapidly corrected within minutes after exposure to an electrolyte solution. The restoration of cell volume after refeeding is associated with stimulation of NHE1 (61).


    REGULATORY VOLUME DECREASE
TOP
ABSTRACT
INTRODUCTION
DETERMINANTS OF CELL VOLUME
REGULATORY VOLUME INCREASE
REGULATORY VOLUME DECREASE
CHANGES IN THE SET...
SUMMARY
REFERENCES

Volume-Regulatory Transporters

The predominant pathway for RVD is the opening of K+ channels and anion channels. The K+ channels involved are usually large-conductance, Ca2+-activated channels (so-called BK channels). The molecular basis of the anion conductance is unknown and may comprise more than one channel (196). The conductance can be quite nonselective and can include a variety of organic anions in addition to Cl- (196), hence the term volume-sensitive organic anion channel (VSOAC). VSOACs are quite ubiquitous, but differences exist between cell types, particularly in the pharmacology of inhibition. Conductance of organic anions in addition to Cl- is appropriate for a volume-regulatory channel because [Cl-]i is often low and could reach equilibrium across the cell membrane before RVD is complete. Furthermore, there is a much greater outward electrochemical gradient for organic anions than for Cl-. However, organic osmolytes are very expensive metabolically, since they must be replaced by synthesis or by uptake from extracellular fluid against a steep concentration gradient. It would be best to use organic anions for RVD only when [Cl-]i is low and this may explain the inhibition of VSOACs by Cl-. When [Cl-]i is above a certain level, VSOACs are inhibited and RVD occurs by Cl- loss through a separate pathway (34, 196). Only when [Cl-]i is low do cells open VSOACs and resort to organic anions for RVD. The "willingness" of cells to sacrifice these compounds attests to the importance of preventing cell swelling. Inhibition of VSOACs by Cl- not only conserves Cl- but also ensures that cells respond appropriately to the cause of swelling. When swelling is due to Cl- uptake, RVD occurs via Cl- loss. In contrast, when swelling is due to accumulation of organic compounds (such as amino acids), Cl- is lost to a certain level (to accommodate the organic compounds) below which the organic osmolytes are lost.

An additional transporter that mediates RVD is the K+-Cl- cotransporter (KCC), which transports K+ and Cl- stoichiometrically in either direction across the plasma membrane (98). Although structurally related to NKCC1 and inhibited by furosemide, this transporter is distinguished by its Na+ independence and insensitivity to bumetanide. Among physiological anions, it has a strict requirement for Cl- and, not surprisingly, is the principal mechanism for RVD in cells with a high [Cl-]i such as erythrocytes. Studies of KCC have been hampered by the lack of a specific inhibitor, but, based on mRNA abundance, the transporter is probably more prevalent than previously thought (47, 48, 132). For instance, it appears to be responsible for about one-half the RVD in aortic endothelial cells (160).

The mechanisms by which cell swelling activates volume-sensitive channels and KCC are poorly understood. The nature of the K+ channels involved suggests Ca2+ as a signal, and evidence in support of this has been obtained primarily in epithelial cells (22, 31, 72, 121, 122, 172, 173, 189, 221). The hypothesis based on these data is that cell swelling induces Ca2+ influx, possibly via stretch-activated channels, leading to a rise in [Ca2+]i and subsequent activation of BK channels. However, in many other cells only a small rise in [Ca2+]i occurs and is not required for activation of K+ efflux (52, 74, 125, 161, 222). One possible explanation for this discrepancy is the distinction between dependence on Ca2+ and activation by Ca2+. The K+ channels may require Ca2+ for activity, but swelling could open them through a separate mechanism. Maneuvers that block increases in [Ca2+]i (such as removing extracellular Ca2+) often lower basal [Ca2+]i, thereby preventing channel activation by any mechanism. Further evidence against the Ca2+ theory is that Ca2+ is not involved in the activation of anion channels or K+-Cl- cotransport in swollen cells. Because the evidence for Ca2+ signaling of RVD is quite compelling in epithelial cells, it is reasonable to hypothesize two pathways for activation of K+ channels by cell swelling: a mechanosensitive Ca2+ influx that is the primary pathway in epithelia and a Ca2+-independent pathway operational in nonepithelial cells. The nature of the Ca2+-independent signal is unknown, but phospholipase A2 has been implicated in volume-sensitive K+ and anion channels (136, 147), whereas protein kinase inhibition has been implicated in the activation of KCC in swollen erythrocytes (11, 82, 84). Unfortunately, it has not yet been possible to determine whether the cotransporter itself is phosphorylated.

Hypotonic vs. Isosmotic Swelling

Essentially all cells (with the exception of some erythrocytes) respond to hypotonic swelling with an RVD, but the response is usually incomplete and cells remain swollen. The failure to complete RVD has remained a mystery, but recent studies in endothelial cells provide an explanation (Fig. 3). When these cells are swollen isosmotically by loading them with KCl, which raises [Cl-]i as opposed to the decrease in [Cl-]i after hypotonic swelling, there was a complete and far more rapid RVD. In fact there was an overshoot that was gradually corrected. Complete RVD could also be accomplished in hypotonic medium by adding bumetanide to inhibit NKCC1. These data indicate that incomplete RVD in hypotonic medium was due to a decrease in [Cl-]i that resulted in net influx via NKCC1. Hypotonic RVD in the presence of bumetanide is still slower than isosmotic RVD, which may be a manifestation of the smaller outward Cl- gradient or stimulation of RVD pathways by Cl-. A similar phenomenon has been described in Ehrlich ascites cells, in which swelling activates Na+/H+ exchange and amiloride enhances RVD (103). Thus incomplete RVD in hypotonic medium does not represent inadequacy of RVD pathways or their sensitivity to cell volume but rather represents a new steady-state volume at which efflux through RVD pathways equals influx through RVI pathways that are activated by a decrease in [Cl-]i. Thus, as with RVI, RVD also depends on how volume is altered and centers on [Cl-]i and its conservation.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Regulatory volume decrease (RVD) in aortic endothelial cells, measured as changes in cell content of Na+ and K+. Top: cells placed in medium made hypotonic by removal of NaCl. Middle: RVD after isosmotic swelling. Cells were preincubated in isosmotic KCl medium and then placed back in standard isosmotic medium. Bottom: Cells were placed in hypotonic medium with 50 µM bumetanide. Dashed line in each panel represents expected values for complete RVD. [Adapted from O'Neill and Klein (143).]

Hypotonic Swelling In Vivo

Despite the fact that mammalian cells regulate their volume in hypotonic medium, the need rarely arises in vivo. At the level of the whole organism, hypotonicity can only occur from excess water intake (in the absence of pathological states), which is possible since thirst is not driven exclusively by osmolarity. For instance, mild hypotonicity will develop when water is provided to rats deprived of water for 10 h (182). As a localized phenomenon, hypotonicity may be more frequent. Ingestion of water can render the intestinal lumen hypotonic, and this can even extend to the liver since portal blood can become hypotonic after water ingestion (71). The RVD exhibited by isolated cells appears to accurately reflect the occurrence of RVD in vivo. In rats made hyponatremic through administration of water and vasopressin, total intracellular water increased far less than predicted and total body K+ decreased (208, 209), consistent with RVD. This is indicative of RVD in skeletal muscle, since it contains most of the cellular water, but hypotonic RVD has also been demonstrated in specific organs including liver (59, 96), heart (151), and brain (195).

Isosmotic Swelling In Vivo

Isosmotic swelling is a much more common occurrence and results from an increase in the cellular content of osmotically active molecules. Examples include uptake of nutrients, acidosis, or depolarization of the cell membrane potential. Uptake of nutrients, particularly amino acids and sugars, can and must occur rapidly in tissues responsible for their assimilation after meals such as intestinal epithelium, liver, and skeletal muscle. In Ehrlich ascites cells, for instance, 10 mM glycine, a physiological postprandial concentration, produces a 17% increase in cell volume through Na+-coupled uptake (77), and a similar response has been noted in intact, perfused liver (71). Nutrient-induced swelling followed by RVD is also observed in mammalian intestine (117). RVD after nutrient uptake is incomplete, probably due to dilution of intracellular Cl-.

Acidosis can also increase cell volume, a response that is distinct and opposite from the effect of pH on the Gibbs-Donnan equilibrium. By titrating negative charges on impermeant molecules, a reduction in pH decreases the tendency of cells to swell. However, this is more than offset by accumulation of the anions that accompany the H+ and replace impermeant anions titrated by the H+ (79). If intracellular buffering capacity is 30 mM/pH unit, lowering cell pH by 0.5 with a monovalent acid would lead to accumulation of 15 mM anion. Cell swelling occurs during all three types of acidosis: organic, inorganic, and respiratory. With organic acids such as lactic acid, the anion accumulates not only within cells in which they are synthesized but also in other cells, because the acids are weak and permeant and because the anions can be transported (105). The resulting swelling has been demonstrated in astrocytes (80, 81, 105) and erythrocytes (191). Hydrochloric acidosis, the principal inorganic acidosis in vivo, can be created in vitro by replacing HCO-3 with Cl-. The assumption is that HCO-3 leaves cells in exchange for Cl-, transmitting the acidosis to the cytoplasm. Because of intracellular buffering, the amount of HCO-3 leaving the cell and replacement anions entering will be greater than the drop in HCO-3 concentration, leading to an increase in osmotically active molecules. In renal proximal tubular cells, a decrease in HCO-3 concentration from 25 to 5 mM increased cell volume by 6% (198), but there was no accumulation of Cl- (199), suggesting a different counteranion. In respiratory acidosis CO2 diffuses into cells and dissociates into H+, which are buffered, and HCO-3, which accumulates and is partly exchanged for extracellular Cl-. Accordingly, an increase in CO2 from 5 to 15% produced swelling of renal proximal tubules accompanied by an increase in the cellular content of both HCO-3 and Cl- (199). An additional mechanism of swelling in acidosis is activation of counterregulatory pathways. In astrocytes exposed to organic acids, activation of NHE1 by intracellular acidification leads to a second phase of swelling (80, 81). It is not known whether RVD occurs during acidification in vitro, and limited data are available in vivo. Respiratory acidosis (10% CO2 for 3 h) did not increase cell water in rat heart, brain, spleen, liver, or skeletal muscle (171), implying that RVD had occurred. In contrast, exposure of rat skeletal muscle to 30% CO2 for 95 min increased cell water by 11% (177), but such severe acidosis may have overwhelmed or inhibited RVD. In muscle biopsies from humans during vigorous exercise, there was a small, insignificant increase in intracellular water despite substantial cellular lactate accumulation (190), again implying some volume correction.

Because the negative membrane potential is largely responsible for maintaining cell volume by limiting Cl- accumulation, depolarization can lead to cell swelling. In vivo, this would be most apparent in excitable tissues such as nerve and muscle, particularly where depolarization is due to opening of Na+ channels. The expected swelling has in fact been demonstrated in nerve fibers (78) and in cultured myogenic cells (185). Although the Na+-K+ pump can rapidly export the excess Na+, much of this is exchanged for K+, with the resulting net efflux of only one osmotically active molecule per cycle. Thus the Na+-K+ pump is an inefficient volume-regulatory transporter that cannot rapidly relieve cell swelling. Swelling of skeletal muscle during repetitive contraction would be particularly problematic since it could compromise regional blood flow. Such swelling occurs during vigorous exercise, accompanied by an increase in Cl- content (123, 190), but the swelling cannot be ascribed solely to repetitive depolarization since acidosis could also contribute to the swelling. The increase in intracellular water is small, implying that volume regulation has occurred. Volume regulation via Ca2+-activated K+ channels could serve the dual purpose of repolarizing the membrane potential (15). A dramatic example of isosmotic swelling in vivo, possibly related to depolarization and acidosis, occurs after ischemia (39, 215). Although ischemia directly swells cells in vitro (92), in vivo this may require reperfusion (215). The marked swelling of endothelium probably contributes to reduced blood flow and further ischemia, since perfusion with hypertonic solutions maintains blood vessel patency and organ perfusion (39), and prevents ischemic damage (2). The cellular events responsible for cell swelling during reperfusion and the role of volume-regulatory transporters are unknown.


    CHANGES IN THE SET POINT FOR STEADY-STATE CELL VOLUME
TOP
ABSTRACT
INTRODUCTION
DETERMINANTS OF CELL VOLUME
REGULATORY VOLUME INCREASE
REGULATORY VOLUME DECREASE
CHANGES IN THE SET...
SUMMARY
REFERENCES

Steady-state volume varies over the life span of a cell, particularly during growth and differentiation. This obviously requires suppression of normal volume-regulatory mechanisms, but volume-regulatory transporters may also play a more direct role. Activation of NHE1 or NKCC1 in the absence of cell shrinkage could lead to cell enlargement, whereas volume-independent activation of RVD pathways could lead to cell shrinkage. Although the role of volume-regulatory transporters in adjusting steady-state cell volume has not been established, the rapid activation of NKCC1 (152, 153, 155, 156, and W. C. O'Neill, J. D. Klein, and S. T. Lamitina, unpublished observations) and NHE1 (60, 175) by growth factors lends credence to this concept. Addition of serum produces a rapid increase in cell volume (15% over 10 min) in endothelial cells, which is mediated by NKCC1 (W. C. O'Neill, J. D. Klein, and S. T. Lamitina, unpublished observations), and a similar response occurs in growth-stimulated fibroblasts (126, 152, 153). A more chronic stimulation of NKCC1 is also seen with growth factors (Ref. 19 and W. C. O'Neill, J. D. Klein, and S. T. Lamitina, unpublished observations) and contributes to the increase in cell volume during the growth cycle (19). This switch in NKCC1 from its normal mode of K+/K+ exchange at steady-state volume to a net influx mode implies that growth stimuli can modulate or overcome the putative inhibitory effect of intracellular Cl-. Activation of NHE1 by growth factors also increases cell volume (51), which, like NKCC1, requires disinhibition of the transporter at steady-state volume, in this case by shifting the pH dependence to the right (51). The mechanism by which growth factors activate NHE1 and NKCC1 is not understood. Phosphorylation of NHE1 is increased (178), but a mutated antiporter lacking phosphorylation sites is still activated by mitogens, although to a lesser degree (210). Regulation of NKCC1 by growth factors has not been examined at the molecular level and, whatever the mechanism, it must overcome the normal inhibition of net influx (presumably due to intracellular Cl-) to increase cell volume. Volume-regulatory transporters may also be responsible for cell enlargement during transformation. Fibroblasts expressing the ras oncogene were found to be 32% larger than control cells, with upregulation of both NKCC1 and NHE1 (95, 126), whereas cell enlargement accompanying cytomegalovirus infection is associated with enhanced activity of NHE1 (27).

Cell shrinkage is an early and dramatic event during apoptosis (6, 7, 149). The mechanism is unknown but appears to be biphasic. In dexamethasone-treated lymphoid cells, shrinkage begins in 12 h and progresses until chromatin condensation (36 h). Although this is associated with a net loss of K+, other cytoplasmic components are lost as well, since buoyant density does not change (7). The second phase of shrinkage after chromatin condensation is due to cellular fragmentation. Apoptotic shrinkage is inhibited by blocking K+ channels (6), but it is not known whether these are the normal volume-regulatory channels. Cell shrinkage also occurs during the latter stages of erythrocyte maturation and may be mediated by the K+-Cl- cotransporter (97, 99), which is expressed predominantly in young erythrocytes (20, 62, 98, 142). Altered regulation of this transporter may induce additional shrinkage that contributes to sickling in hemoglobin SS disease (13).

The mechanism that couples cell volume to cell growth and differentiation is unknown. The macromolecular crowding theory of volume regulation could account for the regulation of volume-regulatory transporters by cell growth. As cell content of protein and other macromolecules changes, cell volume would be perceived as too small or too large, and RVI or RVD would be activated. This is consistent with the constant relative content of cell water during the cell cycle in HeLa cells (131) and the constant buoyant density during early apoptosis in lymphoid cells (7), suggesting a constant ratio of macromolecules to cell water. However, this scenario cannot account for the very early activation of NKCC1 and/or NHE1 and the resulting increase in cell volume produced by growth factors well before any increase in protein content. These data are more consistent with coupling in the other direction, with the increase in cell volume stimulating growth. Such coupling of cell growth to cell volume would ensure, for instance, that cells reach a certain size before mitosis. Consistent with this, inhibition of NKCC1 reduces growth responses in endothelial cells (155) and fibroblasts (19, 126, 139, 140, 154, 156) but not in all studies (1). Inhibition of NHE1 also blunts growth responses in a variety of cells (12, 60, 93, 164, 212), but the effect is variable and it is not clear whether it is mediated through changes in cell volume or intracellular pH (8). Because growth factors often activate both NHE1 and NKCC1, dual inhibition may be required to prevent cell swelling, possibly explaining the failure of amiloride or loop diuretics alone to completely inhibit growth. In fact, studies in fibroblasts showed that both were required to completely block DNA synthesis (154). These results suggest that activation of NHE1 and/or NKCC1 leads to an early increase in cell volume that may signal other aspects of cell growth. The role of cell shrinkage in apoptosis is even less clear. Hypertonic shrinkage is reported to both induce (14, 149) and inhibit (55) apoptosis, and prevention of cell shrinkage with K+ channel blockers does not prevent apoptosis (6).

The concept that cell volume controls cell growth is considerably strengthened by evidence that cell volume also regulates cell metabolism. Swelling (either hypotonic or isosmotic) of hepatocytes (109, 167, 194) increases protein synthesis and decreases protein degradation, whereas hypertonic shrinkage has the opposite effect (71) in liver and in other cells (162). Parallel effects are seen on glycogen synthesis and breakdown (71, 159). This process also represents a volume-regulatory mechanism, since osmotically active molecules are consumed during synthesis of protein and glycogen and released during proteolysis and gycogenolysis. In the liver, changes in cell volume serve to couple metabolism to nutrient uptake and hormone action (71). Nutrient uptake and insulin both cause cell swelling (the latter via stimulation of NKCC1 and NHE1), leading to an increase in the content of protein and glycogen. Prevention of cell swelling by inhibiting NKCC1 and NHE1 blocks this anabolic response. On the other hand, glucagon causes cell shrinkage (probably via opening of K+ channels), thereby inducing a catabolic response (proteolysis and glycogenolysis). There is in fact a linear relationship between hepatocyte volume and protein synthesis and proteolysis along which many anabolic and catabolic stimuli fall (Fig. 4). The anabolic and catabolic effects of cell volume may exist in skeletal muscle as well (106-108), but the role of cell volume in the action of insulin in target tissues other than liver is unclear (223). The signaling mechanisms by which cell volume controls cell metabolism and growth are unknown but could be related to known growth signaling cascades. For instance, cell swelling has been shown to activate tyrosine kinases, phosphorylate (and activate) MAP kinases (180, 204), and to increase c-jun phosphorylation (180), c-jun mRNA abundance (38), and phosphorylation of ribosomal protein S6 (109). To what extent any of these is responsible for the metabolic effects of cell volume is unknown.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 4.   Correlation between cell volume and proteolysis in perfused rat liver. Perturbations included anisosmotic media, hormones, channel and transporter blockers, and nutrients. [Adapted from Haussinger (71).]


    SUMMARY
TOP
ABSTRACT
INTRODUCTION
DETERMINANTS OF CELL VOLUME
REGULATORY VOLUME INCREASE
REGULATORY VOLUME DECREASE
CHANGES IN THE SET...
SUMMARY
REFERENCES

The purpose of this review is to dispel the notion that cell volume regulation in higher organisms is a curious but physiologically irrelevant phenomenon. Osmolarity of the milieu interieure is not as constant as is often assumed, and significant threats to cell volume still exist in an isosmotic environment under both physiological and pathological conditions. In addition to maintaining cell volume, volume-regulatory mechanisms are also employed to initiate changes in cell volume, as required for cell growth and differentiation. The close link between volume-regulatory transporters, cell volume, and cell growth and metabolism indicates that regulation of cell volume is a fundamental and important property of mammalian cells. The sensing and signaling mechanisms for cell volume regulation remain a mystery, and elucidation of these pathways will provide important new information on other aspects of cell physiology as well.


    ACKNOWLEDGEMENTS

I thank Drs. Robert Gunn and Michael Jennings for their helpful comments.


    FOOTNOTES

Studies from the author's laboratory have been supported by National Institutes of Health Grants DK-01643, HL-47449, and DK-50268, the National Kidney Foundation of Georgia, and the American Heart Association, Georgia Affiliate.

Address for reprint requests and other correspondence: W. C. O'Neill, Renal Division, Emory Univ. School of Medicine, WMB 338, 1639 Pierce Dr., Atlanta, GA 30322 (E-mail: woneill{at}emory.edu).


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
DETERMINANTS OF CELL VOLUME
REGULATORY VOLUME INCREASE
REGULATORY VOLUME DECREASE
CHANGES IN THE SET...
SUMMARY
REFERENCES

1.   Amsler, K., J. J. Donahue, C. W. Slayman, and E. A. Adelberg. Stimulation of bumetanide-sensitive K+ transport in swiss 3T3 fibroblasts by serum and mitogenic hormones. J. Cell. Physiol. 123: 257-263, 1985[Medline].

2.   Andrews, P. M., and A. K. Coffey. Protection of kidneys from acute renal failure resulting from normothermic ischemia. Lab. Invest. 49: 87-98, 1983[Medline].

3.   Arieff, A. I., C. R. Kleeman, A. Keushkerian, and H. Bagdoyan. Studies on mechanisms of cerebral edema in diabetic comas: effects of hyperglycemia and rapid lowering of plasma glucose in normal rabbits. J. Clin. Invest. 52: 571-583, 1973[Medline].

4.   Babila, T., H. Atlan, I. Fromer, H. Schwalb, G. Uretzky, and D. Lichtstein. Volume regulation of nerve terminals. J. Neurochem. 55: 2058-2062, 1990[Medline].

5.   Bakker-Grunwald, T. Potassium permeability and volume control in isolated hepatocytes. Biochim. Biophys. Acta 731: 239-242, 1983[Medline].

6.   Beauvais, F., L. Michel, and L. Dubertret. Human eosinophils in culture undergo a striking and rapid shrinkage during apoptosis. Role of K+ channels. J. Leukoc. Biol. 57: 851-855, 1995[Abstract].

7.   Benson, R. S. P., S. Heer, C. Dive, and J. M. Watson. Characterization of cell volume loss in CEM-C7A cells during dexamethasone-induced apoptosis. Am. J. Physiol. 270 (Cell Physiol. 39): C1190-C1203, 1996[Abstract/Free Full Text].

8.   Bianchini, L., and S. Grinstein. Regulation of volume-modulating ion transport systems by growth promoters. Adv. Comp. Environ. Physiol. 14: 249-278, 1993.

9.   Bianchini, L., M. Woodside, C. Sardet, J. Pouyssegur, A. Takai, and S. Grinstein. Okadaic acid, a phosphatase inhibitor, induces activation and phosphorylation of the Na+/H+ antiporter. J. Biol. Chem. 266: 15406-15413, 1991[Abstract/Free Full Text].

10.   Bibby, K. J., and C. A. G. McCulloch. Regulation of cell volume and [Ca2+]i in attached human fibroblasts responding to anisotonic buffers. Am. J. Physiol. 266 (Cell Physiol. 35): C1639-C1649, 1994[Abstract/Free Full Text].

11.   Bize, I., and P. B. Dunham. Staurosporine, a protein kinase inhibitor, activates K-Cl cotransport in LK sheep erythrocytes. Am. J. Physiol. 266 (Cell Physiol. 35): C759-C770, 1994[Abstract/Free Full Text].

12.   Bobik, A., A. Grooms, P. J. Little, E. J. Cragoe, Jr., and S. Grinpukel. Ethylisopropylamiloride-sensitive pH control mechanisms modulate vascular smooth muscle cell growth. Am. J. Physiol. 260 (Cell Physiol. 29): C581-C588, 1991[Abstract/Free Full Text].

13.   Bookchin, R. M., O. E. Ortiz, and V. L. Lew. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia. J. Clin. Invest. 87: 113-124, 1991[Medline].

14.   Bortner, C. D., and J. A. Cidlowski. Absence of volume regulatory mechanisms contributes to the rapid activation of apoptosis in thymocytes. Am. J. Physiol. 271 (Cell Physiol. 40): C950-C961, 1996[Abstract/Free Full Text].

15.   Brayden, J. E., and M. T. Nelson. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 24: 532-535, 1992.

16.   Breitwieser, G. E., A. A. Altamirano, and J. M. Russell. Elevated [Cl-]i and [Na+]i inhibit Na+,K+,Cl- cotransport by different mechanisms in squid giant axons. J. Gen. Physiol. 107: 261-270, 1996[Abstract].

17.   Brown, M. D., and S. Egginton. Capillary density and fine structure in rabbit papillary muscles afer a high dose of norepinephrine. Microvasc. Res. 36: 1-12, 1988[Medline].

18.   Burg, M. B., and A. Garcia-Perez. How tonicity regulates gene expression. J. Am. Soc. Nephrol. 3: 121-127, 1992[Abstract].

19.   Bussolati, O., J. Uggeri, S. Belletti, V. Dall'Asta, and G. C. Gazzola. The stimulation of Na,K,Cl cotransport and of system A for neutral amino acid transport is a mechanism for cell volume increase during cell cycle. FASEB J. 10: 920-926, 1996[Abstract/Free Full Text].

20.   Canessa, M., M. E. Fabry, N. Blumenfeld, and R. L. Nagel. Volume-stimulated, Cl--dependent K+ efflux is highly expressed in young human red cells containing normal hemoglobin or HbS. J. Membr. Biol. 97: 97-105, 1987[Medline].

21.   Chassande, O., C. Frelin, D. Farahifar, T. Jean, and M. Lazdunski. The Na+/K+/Cl- cotransport in C6 glioma cells. Eur. J. Biochem. 171: 425-433, 1988[Abstract].

22.   Christensen, O. Mediation of cell volume regulation by Ca2+ influx through stretch-activated channels. Nature 330: 66-68, 1987[Medline].

23.   Corasanti, J. G., D. Gleeson, and J. L. Boyer. Effects of osmotic stresses on isolated rat hepatocytes. I. Ionic mechanisms of cell volume regulation. Am. J. Physiol. 258 (Gastrointest. Liver Physiol. 21): G290-G298, 1990[Abstract/Free Full Text].

24.   Cornet, M., E. Delpire, and R. Gilles. Study of microfilaments network during volume regulation process of cultured PC 12 cells. Pflügers Arch. 410: 223-225, 1987[Medline].

25.   Cornet, M., I. H. Lambert, and E. K. Hoffmann. Relation between cytoskeleton, hypo-osmotic treatment and volume regulation in Ehrlich ascites tumor cells. J. Membr. Biol. 131: 55-66, 1993[Medline].

26.   Costill, D. L., R. Cote, and W. Fink. Muscle water and electrolytes following varied levels of dehydration in man. J. Appl. Physiol. 40: 6-11, 1976[Abstract/Free Full Text].

27.   Crowe, W. E., A. A. Altamirano, and J. M. Russell. Human cytomegalovirus infection enhances osmotic stimulation of Na+/H+ exchange in human fibroblasts. Am. J. Physiol. 273 (Cell Physiol. 42): C1739-C1748, 1997[Abstract/Free Full Text].

28.   Cserr, H. F., M. DePasquale, and C. S. Patlak. Volume regulatory influx of electrolytes from plasma to brain during acute hyperosmolality. Am. J. Physiol. 253 (Renal Fluid Electrolyte Physiol. 22): F530-F537, 1987[Abstract/Free Full Text].

29.   Cserr, H. F., M. DePasquale, and C. S. Patlak. Regulation of brain water and electrolytes during acute hyperosmolality in rats. Am. J. Physiol. 253 (Renal Fluid Electrolyte Physiol. 22): F522-F529, 1987[Abstract/Free Full Text].

30.   Dall'Asta, V., P. A. Rossi, O. Bussolati, and G. C. Gazzola. Response of human fibroblasts to hypertonic stress. J. Biol. Chem. 269: 10485-10491, 1994[Abstract/Free Full Text].

31.   Davis, C. W., and A. L. Finn. Cell volume regulation in frog urinary bladder. Federation Proc. 44: 2520-2525, 1985[Medline].

32.   Douglas, I. J., and P. D. Brown. Regulatory volume increase in rat lacrimal gland acinar cells. J. Membr. Biol. 150: 209-217, 1998.

33.   Drewnowska, K., and C. M. Baumgarten. Regulation of cellular volume in rabbit ventricular myocytes: bumetanide, chlorothiazide, and ouabain. Am. J. Physiol. 260 (Cell Physiol. 29): C122-C131, 1991[Abstract/Free Full Text].

34.   Emma, F., M. McManus, and K. Strange. Intracellular electrolytes regulate the volume set point of the organic osmolyte/anion channel VSOAC. Am. J. Physiol. 272 (Cell Physiol. 41): C1766-C1775, 1997[Abstract/Free Full Text].

35.   Engstrom, K. G., P.-E. Sandstrom, and J. Sehlin. Volume regulation in mouse pancreatic beta -cells is mediated by a furosemide-sensitive mechanism. Biochim. Biophys. Acta 1091: 145-150, 1998.

36.   Eriksson, P. S., M. Nilsson, M. Wagberg, L. Ronnback, and E. Hansson. Volume regulation of single astroglial cells in primary culture. Neurosci. Lett. 143: 195-199, 1992[Medline].

37.   Farrugia, G., and J. Rae. Effect of volume changes on a potassium current in rabbit corneal epithelial cells. Am. J. Physiol. 264 (Cell Physiol. 33): C1238-C1245, 1993[Abstract/Free Full Text].

38.   Finkenzeller, G., W. Newsome, F. Lang, and D. Haussinger. Increase of c-jun mRNA upon hypo-osmotic cell swelling of rat hepatoma cells. FEBS Lett. 340: 163-166, 1994[Medline].

39.   Flores, J., D. R. DiBona, N. Frega, and A. Leaf. Cell volume regulation and ischemic tissue damage. J. Membr. Biol. 10: 331-343, 1972[Medline].

40.   Foskett, J. K. The role of calcium in the control of volume regulatory transport pathways. In: Cellular and Molecular Physiology of Cell Volume Regulation, edited by K. Strange. Boca Raton, FL: CRC, 1994, p. 259-278.

41.   Foskett, J. K., and J. E. Melvin. Activation of salivary secretion: coupling of cell volume and [Ca2+]i in single cells. Science 244: 1582-1585, 1989[Medline].

42.   Foskett, J. K., and K. R. Spring. Involvement of calcium and cytoskeleton in gallbladder epithelial cell volume regulation. Am. J. Physiol. 248 (Cell Physiol. 17): C27-C36, 1985[Abstract/Free Full Text].

43.   Fu, W. J., M. Kuwahara, E. J. Cragoe, and F. Marumo. Mechanisms of regulatory volume increase in collecting duct cells. Jpn. J. Physiol. 43: 745-757, 1993[Medline].

44.   Gagnon, J., D. Ouimet, H. Nguyen, R. Laprade, C. Le Grimellec, S. Carriere, and J. Cardinal. Cell volume regulation in the proximal convoluted tubule. Am. J. Physiol. 243 (Renal Fluid Electrolyte Physiol. 12): F408-F415, 1982[Abstract/Free Full Text].

45.   Galcheva-Gargova, Z., B. Derijard, I. H. Wu, and R. J. Davis. An osmosensing signal transduction pathway in mammalian cells. Science 265: 806-808, 1994[Medline].

46.   Geck, B., and B. Pfeiffer. Na++K++2Cl- cotransport in animal cells---its role in volume regulation. Ann. NY Acad. Sci. 456: 166-182, 1985[Abstract].

47.   Gerstheimer, F. P., M. Muhleisen, D. Nehring, and V. A. W. Kreye. A chloride-bicarbonate exchanging anion carrier in vascular smooth muscle of the rabbit. Pflügers Arch. 409: 60-66, 1987[Medline].

48.   Gillen, C. M., S. Brill, J. A. Payne, and B. Forbush III. Molecular cloning and functional expression of the K-Cl cotransporter from rabbit, rat, and human. A new member of the cation-chloride cotransporter family. J. Biol. Chem. 271: 16237-16244, 1996[Abstract/Free Full Text].

49.   Gilles, R., E. Delpire, C. Duchene, M. Cornet, and A. Pequeux. The effect of cytochalasin B on the volume regulation response of isolated axons of the green crab carcinus maenas submitted to hypo-osmotic media. Comp. Biochem. Physiol. A Physiol. 85A: 523-525, 1986.

50.   Grinstein, S., C. A. Clarke, and A. Rothstein. Activation of Na+/H+ exchange in lymphocytes by osmotically induced volume changes and by cytoplasmic acidification. J. Gen. Physiol. 82: 619-638, 1983[Abstract].

51.   Grinstein, S., S. Cohen, J. D. Goetz, A. Rothstein, and E. W. Gelfand. Characterization of the activation of Na+/H+ exchange in lymphocytes by phorbol esters: change in cytoplasmic pH dependence of the antiport. Proc. Natl. Acad. Sci. USA 82: 1429-1433, 1985[Abstract].

52.   Grinstein, S., and J. D. Smith. Calcium-independent cell volume regulation in human lymphocytes. J. Gen. Physiol. 95: 97-120, 1990[Abstract].

53.   Grinstein, S., M. Woodside, C. Sardet, J. Pouyssegur, and D. Rotin. Activation of the Na+/H+ antiporter during cell volume regulation. Evidence for a phosphorylation-independent mechanism. J. Biol. Chem. 267: 23823-23828, 1992[Abstract/Free Full Text].

54.   Grunewald, J. M., R. W. Grunewald, and R. K. H. Kinne. Regulation of ion content and cell volume in isolated rat renal IMCD cells under hypertonic conditions. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F13-F19, 1994[Abstract/Free Full Text].

55.   Gulbins, E., J. Welsch, A. Lepple-Wienhuis, H. Heinle, and F. Lang. Inhibition of Fas-induced apoptotic cell death by osmotic cell shrinkage. Biochem. Biophys. Res. Commun. 236: 517-521, 1997[Medline].

56.   Haas, M. Properties and diversity of (Na-K-Cl) cotransporters. Annu. Rev. Physiol. 51: 443-547, 1989[Medline].

57.   Haas, M., D. McBrayer, and C. Lytle. [Cl-]i-dependent phosphorylation of the Na-K-Cl cotransport protein of dog tracheal epithelial cells. J. Biol. Chem. 270: 28955-28961, 1995[Abstract/Free Full Text].

58.   Haas, M., D. G. McBrayer, and J. R. Yankaskas. Dual mechanisms for Na-K-Cl cotransport regulation in airway epithelial cells. Am. J. Physiol. 264 (Cell Physiol. 33): C189-C200, 1993[Abstract/Free Full Text].

59.   Haddad, P., J. S. Beck, J. L. Boyer, and J. Graf. Role of chloride ions in liver cell volume regulation. Am. J. Physiol. 261 (Gastrointest. Liver Physiol. 24): G340-G348, 1991[Abstract/Free Full Text].

60.   Haggerty, J. G., N. Agarwal, K. Amsler, C. W. Slayman, and E. A. Adelberg. Stimulation by serum of the Na+/H+ antiporter in quiescent pig kidney epithelial (LLC-PK1) cells and role of antiporter in the reinitiation of DNA synthesis. J. Cell. Physiol. 132: 173-177, 1987[Medline].

61.   Hajjar, J., W. Aziz, T. F. P. Molski, and R. I. Sha'afi. Stimulation of intestinal Na+/H+ exchange by cell volume changes during fasting and refeeding in rats. Proc. Soc. Exp. Biol. Med. 209: 354-359, 1995[Abstract].

62.   Hall, A. C., and J. C. Ellory. Evidence for the presence of volume-sensitive KCl transport in "young" human red cells. Biochim. Biophys. Acta 858: 317-320, 1986[Medline].

63.   Hall, A. C., E. R. Horwitz, and R. J. Wilkins. The cellular physiology of articular cartilage. Exp. Physiol. 81: 535-545, 1996[Abstract].

64.   Hall, A. C., I. Starks, C. L. Shoults, and S. Rashidbigi. Pathways for K+ transport across the bovine articular chondrocyte membrane and their sensitivity to cell volume. Am. J. Physiol. 270 (Cell Physiol. 39): C1300-C1310, 1996[Abstract/Free Full Text].

65.   Hallows, K. R., and P. A. Knauf. Principles of cell volume regulation. In: Cellular and Molecular Physiology of Cell Volume Regulation, edited by K. Strange. Boca Raton, FL: CRC, 1994, p. 3-30.

66.   Hallows, K. R., F. Y. Law, C. H. Packman, and P. A. Knauf. Changes in cytoskeletal actin content, f-actin distribution, and surface morphology during HL-60 cell volume regulation. J. Cell. Physiol. 167: 60-71, 1996[Medline].

67.   Hallows, K. R., C. H. Packman, and P. A. Knauf. Acute cell volume changes in anisotonic media affect f-actin content of HL-60 cells. Am. J. Physiol. 261 (Cell Physiol. 30): C1154-C1161, 1991[Abstract/Free Full Text].

68.   Hamilton, M. T., D. S. Ward, and P. D. Watson. Effect of plasma osmolality on steady-state fluid shifts in perfused cat skeletal muscle. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R1318-R1323, 1993[Abstract/Free Full Text].

69.   Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811, 1994[Medline].

70.   Handler, J. S., and H. Moo Kwon. Regulation of renal cell organic osmolyte transport by tonicity. Am. J. Physiol. 265 (Cell Physiol. 34): C1449-C1455, 1993[Abstract/Free Full Text].

71.   Haussinger, D. The role of cellular hydration in the regulation of cell function. Biochem. J. 313: 697-710, 1996[Medline].

72.   Hazama, A., and Y. Okada. Ca2+ sensitivity of volume regulatory K+ and Cl- channels in cultured human epithelial cells. J. Physiol. (Lond.) 402: 687-702, 1988[Abstract].

73.   Hempling, H. G., S. Thompson, and A. DuPre. Osmotic properties of human lymphocyte. J. Cell. Physiol. 93: 293-302, 1977[Medline].

74.   Hoffmann, E. K., L. O. Simonsen, and I. H. Lambert. Volume-induced increase of K+ and Cl- permeabilities in Ehrlich ascites tumor cells. Role of internal Ca2+. J. Membr. Biol. 78: 211-222, 1984[Medline].

75.   Horie, H., S. Ikuta, T. Takenaka, and S. Ito. Adaptation of cultured mammalian neurons to a hypotonic environment with age-related response. Brain Res. 477: 233-240, 1989[Medline].

76.   Hossaini-Hilali, J., S. Benlamlih, and K. Dahlborn. Effects of dehydration, rehydration, and hyperhydration in the lactating and non-lactating black Moroccan goat. Comp. Biochem. Physiol. A Physiol. 109A: 1017-1026, 1994[Medline].

77.   Hudson, R. L., and S. G. Schultz. Sodium-coupled glycine uptake by Ehrlich ascites tumor cells results in an increase in cell volume and plasma membrane channel activities. Proc. Natl. Acad. Sci. USA 85: 279-283, 1988[Abstract].

78.   Iwasa, K., I. Tasaki, and R. C. Gibbons. Swelling of nerve fibers associated with action potentials. Science 210: 338-339, 1980[Medline].

79.   Jacobs, M. H., and D. R. Stewart. Osmotic properties of the erythrocyte. J. Cell. Comp. Physiol. 30: 79-89, 1947.

80.   Jakubovicz, D. E., S. Grinstein, and A. Klip. Cell swelling following recovery from acidification of C6 glioma cells: an in vitro model of postischemic brain edema. Brain Res. 435: 138-146, 1987[Medline].

81.   Jakubovicz, D. E., and A. Klip. Lactic acid-induced swelling in C6 glial cells via Na+/H+ exchange. Brain Res. 485: 215-224, 1989[Medline].

82.   Jennings, M. L., and R. K. Schulz. Okadaic acid inhibition of KCl cotransport. J. Gen. Physiol. 97: 799-818, 1991[Abstract].

83.   Kaji, D. M., J. Diaz, and J. C. Parker. Urea inhibits Na-K-2Cl cotransport in medullary thick ascending limb cells. Am. J. Physiol. 272 (Cell Physiol. 41): C615-C621, 1997[Abstract/Free Full Text].

84.   Kaji, D. M., and Y. Tsukitani. Role of protein phosphatase in activation of KCl cotransport in human erythrocytes. Am. J. Physiol. 260 (Cell Physiol. 29): C178-C182, 1991.

85.   Kempski, O., L. Chaussy, U. Gross, M. Zimmer, and A. Baethmann. Volume regulation and metabolism of suspended C6 glioma cells: an in vitro model to study cytotoxic brain edema. Brain Res. 279: 217-228, 1983[Medline].

86.   Khademazad, M., B. Zhang, P. Loessberg, and S. Muallem. Regulation of cell volume by the osteosarcoma cell line UMR-106-01. Am. J. Physiol. 261 (Cell Physiol. 30): C441-C447, 1991[Abstract/Free Full Text].

87.   Kimelberg, H. K., and M. V. Frangakis. Furosemide- and bumetanide-sensitive ion transport and volume control in primary astrocyte cultures from rat brain. Brain Res. 361: 125-134, 1985[Medline].

88.   Kirk, K. L., J. A. Schafer, and D. R. DiBona. Cell volume regulation in rabbit proximal straight tubule perfused in vitro. Am. J. Physiol. 252 (Renal Fluid Electrolyte Physiol. 21): F922-F932, 1987[Abstract/Free Full Text].

89.   Klein, J. D., and W. C. O'Neill. Volume-sensitive myosin phosphorylation in vascular endothelial cells: correlation with Na-K-2Cl cotransport. Am. J. Physiol. 269 (Cell Physiol. 38): C1524-C1531, 1995[Abstract/Free Full Text].

90.   Klein, J. D., P. B. Perry, and W. C. O'Neill. Regulation by cell volume of Na+-K+-2Cl- cotransport in vascular endothelial cells: role of protein phosphorylation. J. Membr. Biol. 132: 243-252, 1993[Medline].

91.   Krump, E., K. Nikitas, and S. Grinstein. Induction of tyrosine phosphorylation and Na+/H+ exchanger activation during shrinkage of human neutrophils. J. Biol. Chem. 272: 17303-17311, 1997[Abstract/Free Full Text].

92.   Laiho, K. U., and B. F. Trump. Relationship of ionic, water, and cell volume changes in cellular injury of Ehrlich ascites tumor cells. Lab. Invest. 31: 207-215, 1974[Medline].

93.   L'Allemain, G., S. Paris, and J. Pouyssegur. Growth factor action and intracellular pH regulation in fibroblasts. J. Biol. Chem. 259: 5809-5815, 1984[Abstract/Free Full Text].

94.   Lang, F., G. L. Busch, M. Ritter, H. Volkl, S. Waldegger, E. Gulbins, and D. Haussinger. Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 78: 247-306, 1998[Abstract/Free Full Text].

95.   Lang, F., M. Ritter, E. Woll, H. Weiss, D. Haussinger, J. Hoflacher, K. Maly, and H. Grunicke. Altered cell volume regulation in ras oncogene expressing NIH fibroblasts. Pflügers Arch. 420: 424-427, 1992[Medline].

96.   Lang, F., T. Stehle, and D. Haussinger. Water, K+, H+, lactate and glucose fluxes during cell volume regulation in perfused rat liver. Pflügers Arch. 413: 209-216, 1989[Medline].

97.   Lauf, P. K., and J. Bauer. Direct evidence for chloride-dependent volume reduction in macrocytic sheep reticulocytes. Biochem. Biophys. Res. Commun. 144: 849-855, 1987[Medline].

98.   Lauf, P. K., J. Bauer, N. C. Adragna, H. Fujise, A. M. M. Zade-Oppen, K. H. Ryu, and E. Delpire. Erythrocyte K-Cl cotransport: properties and regulation. Am. J. Physiol. 263 (Cell Physiol. 32): C917-C932, 1992[Abstract/Free Full Text].

99.   Lauf, P. K., R. B. Zeidler, and H. D. Kim. Pig reticulocytes. V. Development of Rb+ influx during in vitro maturation. J. Cell. Physiol. 121: 284-290, 1984[Medline].

100.   Lee, D. H. K. Terrestrial animals in dry heat: man in the desert. In: Handbook of Physiology. Adaptation to the Environment. Washington, DC: Am. Physiol. Soc., 1964, sect. 4, chapt. 35, p. 551.

101.   Levinson, C. Inability of Ehrlich ascites tumor cells to volume regulate following a hyperosmotic challenge. J. Membr. Biol. 121: 279-288, 1991[Medline].

102.   Livne, A., S. Grinstein, and A. Rothstein. Volume-regulating behavior of human platelets. J. Cell. Physiol. 131: 354-363, 1987[Medline].

103.   Livne, A., and E. K. Hoffmann. Cytoplasmic acidification and activation of Na+/H+ exchange during regulatory volume decrease in Ehrlich ascites tumor cells. J. Membr. Biol. 114: 153-157, 1990[Medline].

104.   Lohr, J. W., and J. J. Grantham. Isovolumetric regulation of isolated S2 proximal tubules in anisotonic media. J. Clin. Invest. 78: 1165-1172, 1986[Medline].

105.   Lomneth, R., S. Medrano, and E. I. Gruenstein. The role of transmembrane pH gradients in the lactic acid induced swelling of astrocytes. Brain Res. 523: 69-77, 1990[Medline].

106.   Low, S. Y., M. J. Rennie, and P. M. Taylor. Modulation of glycogen synthesis in rat skeletal muscle by changes in cell volume. J. Physiol. (Lond.) 495: 299-303, 1996[Abstract].

107.   Low, S. Y., M. J. Rennie, and P. M. Taylor. Signaling elements involoved in amino acid transport responses to altered muscle cell volume. FASEB J. 11: 1111-1117, 1997[Abstract/Free Full Text].

108.   Low, S. Y., P. M. Taylor, and M. J. Rennie. Responses of glutamine transport in cultured rat skeletal muscle to osmotically induced changes in cell volume. J. Physiol. (Lond.) 492.3: 877-885, 1996[Abstract].

109.   Luiken, J. J. F. P., E. F. C. Blommaart, L. Boon, G. M. van Woerkom, and A. J. Meijer. Cell swelling and the control of autophagic proteolysis in hepatocytes: involvement of phosphorylation of ribosomal protein S6. Biochem. Soc. Trans. 22: 508-511, 1994[Medline].

110.   Lytle, C. Activation of the avian erythrocyte Na-K-Cl cotransport protein by cell shrinkage, cAMP, fluoride, and calyculin-A involves phosphorylation at common sites. J. Biol. Chem. 272: 15069-15077, 1997[Abstract/Free Full Text].

111.   Lytle, C., and B. Forbush. Regulatory phosphorylation of the secretory Na-K-Cl cotransporter: modulation by cytoplasmic Cl. Am. J. Physiol. 270 (Cell Physiol. 39): C437-C448, 1996[Abstract/Free Full Text].

112.   MacFarlane, W. V. Terrestrial animals in dry heat: ungulates. In: Handbook of Physiology. Adaptation to the Environment. Washington, DC: Am. Physiol. Soc., 1964, sect. 4, chapt. 33, p. 509.

113.   MacFarlane, W. V., R. J. H. Morris, and B. Howard. Turn-over and distribution of water in desert camels, sheep, cattle and kangaroos. Nature 197: 270-271, 1963.

114.   Mackert, B.-M., F. Staub, J. Peters, A. Baethmann, and O. Kempski. Anoxia in vitro does not induce neuronal swelling or death. J. Neurol. Sci. 139: 39-47, 1996[Medline].

115.   Macknight, A. D. C., and A. Leaf. Regulation of cellular volume. Physiol. Rev. 57: 510-573, 1977[Free Full Text].

116.   MacLeod, R. J., and J. R. Hamilton. Regulatory volume increase in mammalian jejunal villus cells is due to bumetanide-sensitive NaKCl2 cotransport. Am. J. Physiol. 258 (Gastrointest. Liver Physiol. 21): G665-G674, 1990[Abstract/Free Full Text].

117.   MacLeod, R. J., and J. R. Hamilton. Volume regulation initiated by Na+-nutrient cotransport in isolated mammalian villus enterocytes. Am. J. Physiol. 260 (Gastrointest. Liver Physiol. 23): G26-G33, 1991[Abstract/Free Full Text].

118.   Macri, P., S. Breton, M. Marsolais, J.-Y. Lapointe, and R. Laprade. Hypertonicity decreases basolateral K+ and Cl- conductances in rabbit proximal convoluted tubule. J. Membr. Biol. 155: 229-237, 1997[Medline].

119.   Mansell, J. L., and J. S. Clegg. Cellular and molecular consequences of reduced cell water content. Cryobiology 20: 591-612, 1983[Medline].

120.   Mazzoni, M. C., E. Lundgren, K. Arfors, and M. Intaglietta. Volume changes of an endothelial cell monolayer on exposure to anisotonic media. J. Cell. Physiol. 140: 272-280, 1989[Medline].

121.   McCarty, N. A., and R. G. O'Neil. Calcium-dependent control of volume regulation in renal proximal tubule cells. I. Swelling-activated Ca2+ entry and release. J. Membr. Biol. 123: 149-160, 1991[Medline].

122.   McCarty, N. A., and R. G. O'Neil. Calcium signaling in cell volume regulation. Physiol. Rev. 72: 1037-1061, 1992[Abstract/Free Full Text].

123.   McKenna, M. J. The roles of ionic processes in muscular fatigue during intense excercise. Sports Med. 13: 134-145, 1992[Medline].

124.   McManus, M. L., and K. Strange. Acute volume regulation of brain cells in response to hypertonic challenge. Anesthesiology 78: 1132-1137, 1993[Medline].

125.   Medrano, S., and E. Gruenstein. Mechanisms of regulatory volume decrease in UC-11MG human astrocytoma cells. Am. J. Physiol. 264 (Cell Physiol. 33): C1201-C1209, 1993[Abstract/Free Full Text].

126.   Meyer, M., K. Maly, F. Uberall, J. Hoflacher, and H. Grunicke. Stimulation of K+ transport systems by Ha-ras. J. Biol. Chem. 266: 8230-8235, 1991[Abstract/Free Full Text].

127.   Milanick, M. A., and J. F. Hoffman. Ion transport and volume regulation in red blood cells. Ann. NY Acad. Sci. 488: 174-186, 1986[Medline].

128.   Miley, H. E., D. Holden, R. Grint, L. Best, and P. D. Brown. Regulatory volume increase in rat pancreatic beta -cells. Pflügers Arch. 435: 227-230, 1998[Medline].

129.   Minton, A. P., G. C. Colclasure, and J. C. Parker. Model for the role of macromolecular crowding in regulation of cellular volume. Proc. Natl. Acad. Sci. USA 89: 10504-10506, 1992[Abstract].

130.   Montrose, M. H., C. Knoblauch, and H. Murer. Separate control of regulatory volume increase and Na+-H+ exchange by cultured renal cells. Am. J. Physiol. 255 (Cell Physiol. 24): C76-C85, 1988[Abstract/Free Full Text].

131.   Morrill, G. A., and E. Robbins. Changes in intracellular cations during the cell cycle in HeLa cells. Physiol. Chem. Phys. Med. NMR 16: 209-219, 1984[Medline].

132.   Moscat, J., F. Moreno, C. Herrero, C. Lopez, and P. Garcia-Barreno. Endothelial cell growth factor and ionophore A23187 stimulation of production of inositol phosphates in porcine aorta endothelial cells. Proc. Natl. Acad. Sci. USA 85: 659-663, 1988[Abstract].

133.   Mountian, I., K.-Y. Chou, and W. Van Driessche. Electrolyte transport mechanisms involved in regulatory volume increase in C6 glioma cells. Am. J. Physiol. 271 (Cell Physiol. 40): C1041-C1048, 1996[Abstract/Free Full Text].

134.   Mountian, I., and W. Van Driessche. Isovolumetric regulation of C6 rat glioma cells in hyperosmotic media. Am. J. Physiol. 272 (Cell Physiol. 41): C318-C323, 1997[Abstract/Free Full Text].

135.   Natke, E. Cell volume regulation of rabbit cortical collecting tubule in anisotonic media. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F1657-F1665, 1990[Abstract/Free Full Text].

136.   Nilius, B., M. Oike, I. Zahradnik, and G. Droogmans. Activation of a Cl- current by hypotonic volume increase in human endothelial cells. J. Gen. Physiol. 103: 787-805, 1994[Abstract].

137.   Nose, H., T. Morimoto, and K. Ogura. Distribution of water losses among fluid compartments of tissues under thermal dehydration in the rat. Jpn. J. Physiol. 33: 1019-1029, 1983[Medline].

138.   O'Brien, J. A., R. J. Walters, M. A. Valverde, and F. V. Sepulveda. Regulatory volume increase after hypertonicity- or vasoactive-intestinal-peptide-induced cell-volume decrease in small-intestinal crypts is dependent on Na+-K+-2Cl- cotransport. Pflügers Arch. 423: 67-73, 1993[Medline].

139.   O'Brien, T. G., and R. Prettyman. Phorbol esters and mitogenesis: comparison of the proliferative response of parental and Na+ K+ Cl--cotransport-defective BALB/c 3T3 cells to 12-O-tetradecanoylphorbol-13-acetate. J. Cell. Physiol. 130: 377-381, 1987[Medline].

140.   O'Brien, T. G., R. Prettyman, K. S. George, and H. R. Herschman. A phorbol ester-nonproliferative variant of Swiss 3T3 cells is deficient in Na+ K+ Cl- cotransport activity. J. Cell Biol. 134: 302-306, 1988.

141.   O'Donnell, M. E. Role of Na-K-Cl cotransport in vascular endothelial cell volume regulation. Am. J. Physiol. 264 (Cell Physiol. 33): C1316-C1326, 1993[Abstract/Free Full Text].

141a.   Olsen, J. E., R. Sankar, D. Holtzman, A. James, and D. Fleischhacker. Energy-dependent volume regulation in primary cultured cerebral astrocytes. J. Cell. Physiol. 128: 209-215, 1986[Medline].

142.   O'Neill, W. C. Cl-dependent potassium transport in a pure population of volume-regulating human erythocytes. Am. J. Physiol. 256 (Cell Physiol. 25): C858-C864, 1989[Abstract/Free Full Text].

143.   O'Neill, W. C., and J. D. Klein. Regulation of vascular endothelial cell volume by Na-K-2Cl cotransport. Am. J. Physiol. 262 (Cell Physiol. 31): C436-C444, 1992[Abstract/Free Full Text].

145.   O'Neill, W. C., S. T. Lamitina, and J. D. Klein. A volume-sensitive protein kinase that phosphorylates the Na-K-2Cl cotransporter (Abstract). FASEB J. 12: A1023, 1998.

146.   O'Neill, W. C., and D. F. Steinberg. Functional coupling of Na+-K+-2Cl- cotransport and Ca2+-dependent K+ channels in vascular endothelial cells. Am. J. Physiol. 269 (Cell Physiol. 38): C267-C274, 1995[Abstract/Free Full Text].

147.   O'Neill, W. C., A. Tuli, and H. Watkins. A volume-sensitive phospholipase A2 mediates swelling-activated K+ fluxes in vascular endothelial cells (Abstract). J. Am. Soc. Nephrol. 6: A367, 1995.

149.   Orlov, S. N., T. Dam, J. Tremblay, and P. Hamet. Apoptosis in vascular smooth muscle cells: role of cell shrinkage. Biochem. Biophys. Res. Commun. 221: 708-715, 1996[Medline].

150.   Orlov, S. N., J. Tremblay, and P. Hamet. Cell volume in vascular smooth muscle is regulated by bumetanide-sensitive ion transport. Am. J. Physiol. 270 (Cell Physiol. 39): C1388-C1397, 1996[Abstract/Free Full Text].

151.   Page, E., and S. R. Storm. Cat heart muscle in vitro. IX. Cell ion and water contents in anisosmolal solutions. J. Gen. Physiol. 49: 641-653, 1966[Abstract/Free Full Text].

152.   Panet, R. Serum-induced net K+ influx performed by the diuretic-sensitive transport system in quiescent NIH 3T3 mouse fibroblasts. Biochim. Biophys. Acta 813: 141-144, 1995.

153.   Panet, R., I. Amir, and H. Atlan. Fibroblast growth factor induces a transient net K+ influx carried by the bumetanide-sensitive transporter in quiescent BALB/c 3T3 fibroblasts. Biochim. Biophys. Acta 859: 117-121, 1986[Medline].

154.   Panet, R., I. Amir, D. Snyder, L. Zonenshein, H. Atlan, R. Laskov, and A. Panet. Effect of Na+ flux inhibitors on induction of c-fos, c-myc and ODC genes during cell cycle. J. Cell. Physiol. 140: 161-168, 1989[Medline].

155.   Panet, R., M. Markus, and H. Atlan. Bumetanide and furosemide inhibited vascular endothelial cell proliferation. J. Cell. Physiol. 158: 121-127, 1994[Medline].

156.   Paris, S., and J. Pouyssegur. Growth factors activate the bumetanide-sensitive Na+/K+/Cl- cotransport in hamster fibroblasts. J. Biol. Chem. 261: 6177-6183, 1986[Abstract/Free Full Text].

157.   Parker, J. C. In defense of cell volume? Am. J. Physiol. 265 (Cell Physiol. 34): C1191-C1200, 1993[Abstract/Free Full Text].

158.   Parker, J. C., H. J. Gitelman, P. S. Glosson, and D. L. Leonard. Role of calcium in volume regulation by dog red blood cells. J. Gen. Physiol. 65: 84-96, 1975[Abstract].

159.   Peak, M., M. Al-Habori, and L. Agius. Regulation of glycogen synthesis and glycolysis by insulin, pH and cell volume. Biochem. J. 282: 797-805, 1992[Medline].

160.   Perry, P. B., and W. C. O'Neill. Swelling-activated K fluxes in vascular endothelial cells: volume regulation via K-Cl cotransport and K channels. Am. J. Physiol. 265 (Cell Physiol. 34): C763-C769, 1993[Abstract/Free Full Text].

161.   Perry, P. B., and W. C. O'Neill. Swelling-activated K+ fluxes in vascular endothelial cells: role of intracellular Ca2+. Am. J. Physiol. 267 (Cell Physiol. 36): C1535-C1542, 1994[Abstract/Free Full Text].

162.   Petronini, P. G., E. M. De Angelis, P. Borghetti, A. F. Borghetti, and K. P. Wheeler. Modulation by betaine of cellular responses to osmotic stress. Biochem. J. 282: 69-73, 1992[Medline].

163.   Pewitt, E. B., R. S. Hedge, M. Haas, and H. C. Palfrey. The regulation of Na/K/2Cl cotransport and bumetanide binding in avian erythrocytes by protein phosphorylation and dephosphorylation. J. Biol. Chem. 265: 20747-20756, 1990[Abstract/Free Full Text].

164.   Pouyssegur, J., C. Sardet, A. Franchi, G. L'Allemain, and S. Paris. A specific mutation abolishing Na+/H+ antiport activity in hamster fibroblasts precludes growth at neutral and acidic pH. Proc. Natl. Acad. Sci. USA 81: 4833-4837, 1984[Abstract].

165.   Poznansky, M., and A. K. Solomon. Regulation of human red cell volume by linked cation fluxes. J. Membr. Biol. 10: 259-266, 1972.

166.   Ritter, M., M. Steidl, and F. Lang. Inhibition of ion conductances by osmotic shrinkage of Madin-Darby canine kidney cells. Am. J. Physiol. 261 (Cell Physiol. 30): C602-C607, 1991[Abstract/Free Full Text].

167.   Rivas, T., E. Urcelay, C. Gonzalez-Manchon, R. Parrilla, and M. S. Ayuso. Role of amino acid-induced changes in ion fluxes in the regulation of hepatic protein synthesis. J. Cell. Physiol. 163: 277-284, 1995[Medline].

168.   Robertson, M. A., and K. J. Foskett. Na+ transport pathways in secretory acinar cells: membrane cross talk mediated by [Cl-]i. Am. J. Physiol. 267 (Cell Physiol. 36): C146-C156, 1994[Abstract/Free Full Text].

169.   Robin, E. D., and J. Theodore. Intracellular and subcellular oedema and dehydration. Ciba Found. Symp. 38: 273-289, 1976[Medline].

170.   Rome, L., J. J. Grantham, V. Savin, J. Lohr, and C. Lechene. Proximal tubule volume regulation in hyperosmotic media: intracellular K+, Na+, and Cl-. Am. J. Physiol. 257 (Cell Physiol. 26): C1093-C1100, 1989[Abstract/Free Full Text].

171.   Rothe, K. F. Fractional extracellular space and fractional water content of various rat tissues at different extracellular pH values and in uremia. Lab. Anim. 13: 171-174, 1979[Medline].

172.   Rothstein, A., and E. Mack. Volume-activated K+ and Cl- pathways of dissociated epithelial cells (MDCK): role of Ca2+. Am. J. Physiol. 258 (Cell Physiol. 27): C827-C834, 1990[Abstract/Free Full Text].

173.   Rothstein, A., and E. Mack. Volume-activated calcium uptake: its role in cell volume regulation of Madin-Darby canine kidney cells. Am. J. Physiol. 262 (Cell Physiol. 31): C339-C347, 1992[Abstract/Free Full Text].

174.   Roy, G., and R. Sauve. Effect of anisotonic media on volume, ion and amino-acid content and membrane potential of kidney cells (MDCK) in culture. J. Membr. Biol. 100: 83-96, 1987[Medline].

175.   Rozengurt, E. Early signals in the mitogenic response. Science 234: 161-166, 1986[Medline].

176.   Sackin, H. Mechanosensitive channels. Annu. Rev. Physiol. 57: 333-353, 1995[Medline].

177.   Sahlin, K., L. Edstrom, and H. Sjoholm. Fatigue and phosphocreatine depletion during carbon dioxide-induced acidosis in rat muscle. Am. J. Physiol. 245 (Cell Physiol. 14): C15-C20, 1983[Abstract/Free Full Text].

178.   Sardet, C., L. Counillon, A. Franchi, and J. Pouyssegur. Growth factors induce phosphorylation of the Na+/H+ antiporter, a glycoprotein of 110 kD. Science 247: 723-726, 1990[Medline].

179.   Sarkadi, B., L. Attisano, S. Grinstein, M. Buchwald, and A. Rothstein. Volume regulation of Chinese hamster ovary cells in anisoosmotic media. Biochim. Biophys. Acta 774: 159-168, 1984[Medline].

180.   Schliess, F., R. Schreiber, and D. Haussinger. Activation of extracellular signal-regulated kinases Erk-1 and Erk-2 by cell swelling in H4IIE hepatoma cells. Biochem. J. 309: 13-17, 1995[Medline].

181.   Schmidt-Nielsen, K. Terrestrial animals in dry heat: desert rodents. In: Handbook of Physiology. Adaptation to the Environment. Washington, DC: Am. Physiol. Soc., 1964, sect. 4, chapt. 32, p. 493.

182.   Schoorlemmer, G. H. M., and M. D. Evered. Water and solute balance in rats during 10 h water deprivation and rehydration. Can. J. Physiol. Pharmacol. 71: 379-386, 1993[Medline].

183.   Schultz, S. G. Homocellular regulatory mechanisms in sodium-transporting epithelia: avoidance of extinction by "flush-through." Am. J. Physiol. 241 (Renal Fluid Electrolyte Physiol. 10): F579-F590, 1981[Abstract/Free Full Text].

184.   Schwiebert, E. M., J. W. Mills, and B. A. Stanton. Actin-based cytoskeleton regulates a chloride channel and cell volume in a renal cortical collecting duct cell line. J. Biol. Chem. 269: 7081-7089, 1994[Abstract/Free Full Text].

185.   Sen, C. K., O. Hanninen, and S. N. Orlov. Unidirectional sodium and potassium flux in myogenic L6 cells: mechanisms and volume-dependent regulation. J. Appl. Physiol. 78: 272-281, 1995[Abstract/Free Full Text].

186.   Serrani, R. E., I. A. Gioia, and J. L. Corchs. Human neonatal red cells. Regulatory volume response under anisotonic conditions. Arch. Int. Physiol. Biochim. Biophys. 99: 473-477, 1991[Medline].

187.   Shepard, J. M., S. K. Goderie, N. Brzyski, P. J. Del Vecchio, A. B. Malik, and H. K. Kimelberg. Effects of alterations in endothelial cell volume on transendothelial albumin permeability. J. Cell. Physiol. 133: 389-394, 1987[Medline].

188.   Shrode, L. D., J. D. Klein, W. C. O'Neill, and R. W. Putnam. Shrinkage-induced activation of Na+/H+ exchange in primary rat astrocytes: role of myosin light chain kinase. Am. J. Physiol. 269 (Cell Physiol. 38): C257-C266, 1995[Abstract/Free Full Text].

189.   Simmons, N. L. Epithelial cell volume regulation in hypotonic fluids: studies using a model tissue culture renal epithelial cell system. Q. J. Exp. Physiol. 69: 83-95, 1984[Medline].

190.   Sjogaard, G., and B. Saltin. Extra- and intracellular water spaces in muscles of man at rest and with dynamic exercise. Am. J. Physiol. 243 (Regulatory Integrative Comp. Physiol. 12): R271-R280, 1982[Abstract/Free Full Text].

191.   Smith, J. A., R. D. Telford, M. Kolbuch-Braddon, and M. J. Weidemann. Lactate/H+ uptake by red blood cells during exercise alters their physical properties. Eur. J. Appl. Physiol. 75: 54-61, 1997.

192.   Sotos, J. F., P. R. Dodge, P. Meara, and N. B. Talbot. Studies in experimental hypertonicity: pathogenesis of the clinical syndrome, biochemical abnormalities and cause of death. Pediatrics 26: 925-936, 1960[Abstract].

193.   Stallone, J. N., and E. J. Braun. Regulation of plasma antidiuretic hormone in the dehydrated kangaroo rat (Dipodomys spectabilis M.). Gen. Comp. Endocrinol. 69: 119-127, 1988[Medline].

194.   Stoll, B., W. Gerok, F. Lang, and D. Haussinger. Liver cell volume and protein synthesis. Biochem. J. 287: 217-222, 1992[Medline].

195.   Strange, K. Regulation of solute and water balance and cell volume in the central nervous system. J. Am. Soc. Nephrol. 3: 12-27, 1992[Abstract].

196.   Strange, K., F. Emma, and P. S. Jackson. Cellular and molecular physiology of volume sensitive anion channels. Am. J. Physiol. 270 (Cell Physiol. 39): C711-C730, 1996[Abstract/Free Full Text].

197.   Strange, K., and K. R. Spring. Cell membrane water permeability of rabbit cortical collecting duct. J. Membr. Biol. 96: 27-43, 1987[Medline].

198.   Sullivan, L. P., D. P. Wallace, R. L. Clancy, and J. J. Grantham. Effect of cellular acidosis on cell volume in S2 segments of renal proximal tubules. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F831-F839, 1990[Abstract/Free Full Text].

199.   Sullivan, L. P., D. P. Wallace, R. L. Clancy, C. Lechene, and J. J. Grantham. Cellular electrolyte and volume changes induced by acidosis in the rabbit proximal straight tubule. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F831-F839, 1990[Abstract/Free Full Text].

200.   Summers, J. C., L. Trais, R. Lajvardi, D. Hergan, R. Buechler, H. Chang, C. Peña-Rasgado, and H. Rasgado-Flores. Role of concentration and size of intracellular macromolecules in cell volume regulation. Am. J. Physiol. 273 (Cell Physiol. 42): C360-C370, 1997[Abstract/Free Full Text].

201.   Sun, A., and S. C. Hebert. Rapid hypertonic cell volume regulation in the perfused inner medullary collecting duct. Kidney Int. 36: 831-842, 1989[Medline].

202.   Sun, A. M., S. N. Saltzberg, D. Kikeri, and S. C. Hebert. Mechanisms of cell volume regulation by the mouse medullary thick ascending limb of Henle. Kidney Int. 38: 1019-1029, 1990[Medline].

203.   Takeda, M., T. Homma, M. D. Breyer, N. Horiba, R. L. Hoover, S. Kawamoto, I. Ichikawa, and V. Kon. Volume and agonist-induced regulation of myosin light-chain phosphorylation in glomerular mesangial cells. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F421-F426, 1993[Abstract/Free Full Text].

204.   Tilly, B. C., N. van den Berghe, L. G. J. Tertoolen, M. J. Edixhoven, and H. R. de Jonge. Protein tyrosine phosphorylation is involved in osmoregulation of ionic conductances. J. Biol. Chem. 268: 19919-19922, 1993[Abstract/Free Full Text].

205.   Tivey, D. R., N. L. Simmons, and J. F. Aiton. Role of passive potassium fluxes in cell volume regulation in cultured HeLa cells. J. Membr. Biol. 87: 93-105, 1985[Medline].

206.   Toyomoto, T., D. Knutsen, G. Soos, and K. Sato. Na-K-2Cl cotransporters are present and regulated in simian eccrine clear cells. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R270-R277, 1997[Abstract/Free Full Text].

207.   Uchida, S., A. Garcia-Perez, H. Murphy, and M. Burg. Signal for induction of aldose reductase in renal medullary cells by high external NaCl. Am. J. Physiol. 256 (Cell Physiol. 25): C614-C620, 1989[Abstract/Free Full Text].

208.   Verbalis, J. G., and M. D. Drutarosky. Pathogenesis of hyponatremia in an experimental model of the syndrome of inappropriate antidiuresis. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R1617-R1625, 1994[Abstract/Free Full Text].

209.   Verbalis, J. G., M. D. Drutarosky, R. J. Ertel, and R. R. Vollmer. Adaptive responses to sustained volume expansion in hyponatraemic rats. J. Endocrinol. 122: 421-431, 1989[Abstract].

210.   Wakabayashi, S., B. Bertrand, M. Shigekawa, P. Fafournoux, and J. Pouyssegur. Growth factor activation and "H+-sensing" of the Na+/H+ exchanger isoform I (NHE1). J. Biol. Chem. 269: 5583-5588, 1994[Abstract/Free Full Text].

211.   Walters, R. J., J. A. O'Brien, M. A. Valverde, and F. V. Sepulveda. Membrane conductance and cell volume changes evoked by vasoactive intestinal polypeptide and carbachol in small intestinal crypts. Pflügers Arch. 421: 598-605, 1992[Medline].

212.   Wang, H., D. Singh, and L. Fliegel. The Na+/H+ antiporter potentiates growth and retinoic acid-induced differentiation of P19 embryonal carcinoma cells. J. Biol. Chem. 272: 26545-26549, 1997[Abstract/Free Full Text].

213.   Wangensteen, D., H. Bachofen, and E. R. Weibel. Lung tissue volume changes induced by hypertonic NaCl: morphometric evaluation. J. Appl. Physiol. 51: 1443-1450, 1981[Abstract/Free Full Text].

214.   Wehner, F., H. Sauer, and R. K. H. Kinne. Hypertonic stress increases the Na+ conductance of rat hepatocytes in primary culture. J. Gen. Physiol. 105: 507-535, 1995[Abstract].

215.   Whalen, D. A., D. G. Hamilton, C. E. Ganote, and R. B. Jennings. Effect of a transient period of ischemia on myocardial cells. Am. J. Pathol. 74: 381-397, 1974[Medline].

216.   White, H. L., and D. Rolf. Osmometric behavior of blood cells and of whole body cells. Am. J. Physiol. 202: 1195-1199, 1962.

217.   Wilkerson, E. H., D. R. DiBona, and J. A. Schafer. Analysis of structural changes during hypotonic swelling in Ehrlich ascites tumor cells. Am. J. Physiol. 251 (Cell Physiol. 20): C104-C114, 1986[Abstract/Free Full Text].

219.   Wojnowski, L., and H. Oberleithner. Hypertonicity in fused Madin-Darby canine kidney cells: transient rise in NaHCO3 followed by sustained KCl accumulation (Abstract). Pflügers Arch. 419: 43-50, 1991[Medline].

220.   Wojtaszek, P. A., L. E. Heasley, G. Siriwardana, and T. Berl. Dominant-negative c-Jun NH2-terminal kinase 2 sensitizes renal inner medullary collecting duct cells to hypertonicity-induced lethality independent of organic osmolyte transport. J. Biol. Chem. 273: 800-804, 1998[Abstract/Free Full Text].

221.   Wong, S. M. E., and H. S. Chase, Jr. Role of intracellular calcium in cellular volume regulation. Am. J. Physiol. 250 (Cell Physiol. 19): C842-C852, 1986.

222.   Yamaguchi, D. T., J. Green, C. R. Kleeman, and S. Muallem. Characterization of volume-sensitive calcium permeating pathways in the osteosarcoma cell line UMR-106-01. J. Biol. Chem. 264: 4383-4390, 1989[Abstract/Free Full Text].

223.   Zhande, R., and R. W. Brownsey. Cell volume and the metabolic actions of insulin. Biochem. Cell Biol. 74: 513-522, 1996[Medline].

224.   Zucker, A., S. D. Gleason, and E. G. Schneider. Renal and endocrine response to water deprivation in dog. Am. J. Physiol. 242 (Regulatory Integrative Comp. Physiol. 11): R296-R302, 1982[Medline].


Am J Physiol Cell Physiol 276(5):C995-C1011
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society